[Urachal cancers]

Bull Cancer. 2013 May;100(5):509-17. doi: 10.1684/bdc.2013.1718.
[Article in French]

Abstract

Urachal cancer is a rare pathology (less than 1% among all bladder tumors) with a poor prognosis for all stages, because of clinical delay leading to a late diagnosis, difficult differential diagnosis with bladder cancer, and no consensus for the treatment, mostly about the chemotherapy for advanced stages, because there are no data from prospective studies. A surgical treatment can be performed for the localized stages, but there are no real guidelines for local relapses and metastatic progression treatment. Those cancers are not radio- or chemosensitive; nevertheless data from fundamental research are missing. As this pathology is really uncommon, there are no clinical studies with targeted therapies. The purpose of this review is to introduce the most important clinical and paraclinical features of those cancers, and the usual treatment performed.

Keywords: chemotherapy; review; urachus.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Humans
  • Neoplasm Staging
  • Prognosis
  • Rare Diseases* / diagnosis
  • Rare Diseases* / pathology
  • Rare Diseases* / therapy
  • Urinary Bladder Neoplasms* / diagnosis
  • Urinary Bladder Neoplasms* / pathology
  • Urinary Bladder Neoplasms* / therapy

Supplementary concepts

  • Urachal cancer